24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
ENZYME DYNAMICS |
63.04% |
|
PEPTIDOMIMETIC CD40L BINDING |
35.87% |
|
ALZHEIMERS |
1.09% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
ENZYME DYNAMICS |
56.55% |
|
PEPTIDOMIMETIC CD40L BINDING |
34.64% |
|
ATSTP10 TRANSPORT SIMULATION |
3% |
|
ALZHEIMERS |
2.81% |
|
ATSTP10 SUCROSE TRANSPORT |
1.31% |
|
MEMBRANE TRANSPORT |
1.31% |
|
SUCROSE TRANSPORTER ATSUC1 |
.37% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
ENZYME DYNAMICS |
38.3% |
|
PEPTIDOMIMETIC CD40L BINDING |
25.91% |
|
CANCER |
17.54% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATIONS |
10.2% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATION DYNAMICS |
2.33% |
|
ALZHEIMERS |
2.3% |
|
SUCROSE TRANSPORTER ATSUC1 |
1.07% |
|
ATSTP10 TRANSPORT SIMULATION |
.97% |
|
ATSTP10 SUCROSE TRANSPORT |
.65% |
|
MEMBRANE TRANSPORT |
.5% |
|
NIPAH VIRUS DECOY PROTEIN DYNAMICS |
.18% |
|
NIPAH VIRUS DECOY PROTEINS |
.05% |